Poviztra to be sold as 2.4 mg injectable; Emcure becomes first Indian firm with exclusive semaglutide distribution rights ...

Novo Nordisk partners with Emcure to promote Wegovy, following Eli Lilly's recent collaboration with Cipla for tirzepatide in ...

Novo Nordisk India has joined forces with Emcure Pharmaceuticals to commercialize Poviztra, a weight-loss drug, in an effort ...

The partnership comes just five months after Wegovy debuted in India, and signals Novo Nordisk’s intent to scale access ...

Novo Nordisk and Emcure Pharma team up to bring Poviztra, a new weight loss injection, to India. Learn more about this latest ...

Just five months after Novo Nordisk launched Wegovy in India, the Danish company has partnered (PDF) with Emcure ...

The collaboration gives Emcure exclusive rights to distribute and commercialise semaglutide for chronic weight management in India.

Our Bureau, Mumbai Monday, November 10, 2025, 12:45 Hrs [IST] ...

Macter International Limited (PSX: MACTER) has launched Semaglutide in Pakistan in Pre-Filled Syringe (PFS) and Pre-Filled ...

The deal will help expand the availability and marketing of this weight-loss medicine, especially in areas where Novo Nordisk ...

During the first quarter earnings call, the management of Shaily Engineering had highlighted that the contribution of the ...

The stock fell as much as 17.13 per cent during the session to hit an intraday low of Rs 2,116.30, before recovering some lost ground to close 10.05 per cent lower at Rs 2297 on BSE.